Semaglutide denied for missing prior authorization by Aetna?

Aetna's specific coverage criteria for semaglutide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Requires Prior Authorization for Semaglutide — and How to Win It

Prior authorization (PA) for semaglutide is one of the most common denial types, and it is also one of the most winnable on appeal. Aetna uses PA to verify that clinical criteria are met before coverage begins. A denial at this stage typically means either that no PA request was submitted, the submitted request was missing documentation, or Aetna determined the clinical criteria were not met by the information provided.

## Your Federal Appeal Rights

• ERISA §503 / ACA §2719 internal appeal: You have the right to a full-and-fair review of any adverse benefit determination. Request the specific clinical criteria Aetna applied — you are entitled to that information.
• External review (ACA §2719): If your internal appeal is denied, an independent IRO reviews the clinical decision de novo. File within the window shown on your final denial, typically within four months.
• Expedited option: If your condition is urgent, request simultaneous expedited internal and external review. Decisions are generally required within 72 hours of a complete expedited request.

## What to Gather

1. Aetna's PA criteria document for semaglutide — request the Clinical Policy Bulletin by name from Aetna. This is the exact standard the reviewer used. 2. FDA-approved labeling for the prescribed product — confirms the indication and the clinical profile the drug is approved for. 3. Diagnosis confirmation: Office notes, lab results, and ICD codes establishing the qualifying diagnosis. 4. Prior therapy history with dates and outcomes: If Aetna requires documented failure of earlier treatments, you need dates started, dates stopped, and clinical reason for discontinuation for each. 5. Prescriber medical-necessity letter: Should map your clinical presentation to each criterion in Aetna's PA policy using your chart language, not generic language. 6. Specialty society guideline reference: Your prescriber may cite the applicable guideline organization (e.g., ADA Standards of Care, Obesity Society guidelines) as support — without needing to quote specific numeric thresholds.

## Criteria-Mapping Structure

Obtain Aetna's Clinical Policy Bulletin. List every criterion as a row. For each row, note the chart evidence that satisfies it — diagnosis date, relevant lab, prior-drug name with start/stop dates, and your prescriber's clinical rationale. A well-structured criteria map often resolves PA denials at the peer-to-peer or first internal appeal stage without going to external review.

## Practical Timeline

• Day 1: Request the Clinical Policy Bulletin and the denial reason in writing.
• Days 2–7: Gather chart documentation and coordinate the prescriber letter.
• Day 8–14: Submit the complete appeal package via certified mail or Aetna's provider portal, retaining a copy.
• Track your deadlines: Internal decisions are typically due within 30 days (non-urgent) or 72 hours (expedited). Note these on your calendar.